Long noncoding RNA HULC is a novel biomarker of poor prognosis in patients with pancreatic cancer

Medical Oncology

Volumn 31, Issue 12, 2014, Pages 1-7

  Peng, Wei ^a   Gao, Wei ^b   Feng, Jifeng ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b AFFILIATED ZHONGDA HOSPITAL OF SOUTHEAST UNIVERSITY   (China)

Author keywords

Biomarker; HULC; Long noncoding RNAs; Pancreatic cancer; Prognosis

Indexed keywords

LONG UNTRANSLATED RNA; TUMOR MARKER; HULC LONG NON-CODING RNA, HUMAN;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SIZE; CANCER SURVIVAL; CANCER TISSUE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PANCREAS CANCER; PREDICTOR VARIABLE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; TUMOR DIFFERENTIATION; TUMOR INVASION; UPREGULATION; AGED; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; MIDDLE AGED; MORTALITY; PANCREAS TUMOR; PATHOLOGY; PROGNOSIS; REFERENCE VALUE; SURVIVAL;

AGED; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REFERENCE VALUES; RNA, LONG NONCODING; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84919951392     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-014-0346-4     Document Type: Article

References (24)

1. Wolfgang CL, Herman JM, Laheru DA, Klein AP, Erdek MA, Fishman EK, et al. Recent progress in pancreatic cancer. CA Cancer J Clin. 2013;63(5):318–48. doi:10.3322/caac.21190.
2. Ryan DP, Hong TS, Bardeesy N. Pancreatic adenocarcinoma. N Engl J Med. 2014;371(11):1039–49. doi:10.1056/NEJMra1404198.
3. Crawford SM. The importance of primary care for cancer diagnoses. Lancet Oncol. 2014;15(2):136–7. doi:10.1016/S1470-2045(14)70013-0.
4. Mattick JS, Makunin IV. Non-coding RNA. Human molecular genetics. 2006;15 Spec No 1:R17-29. doi:10.1093/hmg/ddl046.
5. Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009;10(3):155–9. doi:10.1038/nrg2521.
6. Taft RJ, Pang KC, Mercer TR, Dinger M, Mattick JS. Non-coding RNAs: regulators of disease. J Pathol. 2010;220(2):126–39. doi:10.1002/path.2638.
7. Gibb EA, Brown CJ, Lam WL. The functional role of long non-coding RNA in human carcinomas. Mol Cancer. 2011;10. doi:10.1186/1476-4598-10-38.
8. Yang Z, Zhou L, Wu LM, Lai MC, Xie HY, Zhang F, et al. Overexpression of long non-coding RNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation. Ann Surg Oncol. 2011;18(5):1243–50. doi:10.1245/s10434-011-1581-y.
9. Kim K, Jutooru I, Chadalapaka G, Johnson G, Frank J, Burghardt R, et al. HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer. Oncogene. 2013;32(13):1616–25. doi:10.1038/onc.2012.193.
10. Nie Y, Liu X, Qu SH, Song EW, Zou H, Gong C. Long non-coding RNA HOTAIR is an independent prognostic marker for nasopharyngeal carcinoma progression and survival. Cancer Sci. 2013;104(4):458–64. doi:10.1111/cas.12092.
11. Lai MC, Yang Z, Zhou L, Zhu QQ, Xie HY, Zhang F, et al. Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med Oncol. 2012;29(3):1810–6. doi:10.1007/s12032-011-0004-z.
12. Han YH, Liu YC, Zhang H, Wang TT, Diao RY, Jiang ZM, et al. Hsa-miR-125b suppresses bladder cancer development by down-regulating oncogene SIRT7 and oncogenic long non-coding RNA MALAT1. FEBS Lett. 2013;587(23):3875–82. doi:10.1016/j.febslet.2013.10.023.
13. Ji Q, Zhang L, Liu X, Zhou L, Wang W, Han Z, et al. Long non-coding RNA MALAT1 promotes tumour growth and metastasis in colorectal cancer through binding to SFPQ and releasing oncogene PTBP2 from SFPQ/PTBP2 complex. Br J Cancer. 2014;111(4):736–48. doi:10.1038/bjc.2014.383.
14. Jiang Y, Li YH, Fang SJ, Jiang BY, Qin CF, Xie PL, et al. The role of MALAT1 correlates with HPV in cervical cancer. Oncol Lett. 2014;7(6):2135–41. doi:10.3892/ol.2014.1996.
15. Ren SC, Liu YW, Xu WD, Sun Y, Lu J, Wang FB, et al. Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer. J Urol. 2013;190(6):2278–87. doi:10.1016/j.juro.2013.07.001.
16. Wang JQ, Su LP, Chen XH, Li P, Cai Q, Yu BQ, et al. MALAT1 promotes cell proliferation in gastric cancer by recruiting SF2/ASF. Biomed Pharmacother. 2014;68(5):557–64. doi:10.1016/j.biopha.2014.04.007.
17. Wu XS, Wang XA, Wu WG, Hu YP, Li ML, Ding Q, et al. MALAT1 promotes the proliferation and metastasis of gallbladder cancer cells by activating the ERK/MAPK pathway. Cancer Biol Ther. 2014;15(6):806–14. doi:10.4161/cbt.28584.
18. Kam Y, Rubinstein A, Naik S, Djavsarov I, Halle D, Ariel I, et al. Detection of a long non-coding RNA (CCAT1) in living cells and human adenocarcinoma of colon tissues using FIT-PNA molecular beacons. Cancer Lett. 2014;352(1):90–6. doi:10.1016/j.canlet.2013.02.014.
19. Crea F, Watahiki A, Quagliata L, Xue H, Pikor L, Parolia A, et al. Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer. Oncotarget. 2014;5(3):764–74.
20. Wang JY, Liu XF, Wu HC, Ni PH, Gu ZD, Qiao YX, et al. CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res. 2010;38(16):5366–83. doi:10.1093/nar/gkq285.
21. Zhao Y, Guo QH, Chen JJ, Hu J, Wang SW, Sun YM. Role of long non-coding RNA HULC in cell proliferation, apoptosis and tumor metastasis of gastric cancer: a clinical and in vitro investigation. Oncol Rep. 2014;31(1):358–64. doi:10.3892/or.2013.2850.
22. Liu Y, Pan SD, Liu L, Zhai XJ, Liu JB, Wen J et al. A genetic variant in long non-coding RNA HULC contributes to risk of HBV-related hepatocellular carcinoma in a Chinese population. Plos One. 2012;7(4). doi:10.1371/journal.pone.0035145.
23. Huang JL, Zheng L, Hu YW, Wang Q. Characteristics of long non-coding RNA and its relation to hepatocellular carcinoma. Carcinogenesis. 2014;35(3):507–14. doi:10.1093/carcin/bgt405.
24. Hidalgo M. Pancreatic cancer. N Engl J Med. 2010;362(17):1605–17. doi:10.1056/NEJMra0901557.